Product Guides / Services and Equipment
Stem Cell and Regenerative-Medicine Clinic Vetting Guide
Humanic Blue’s Longevity365 guide: The phrase stem-cell therapy can refer to a person’s own bone marrow, fat-derived cells or donor cells grown in a laboratory. These five providers advertise different materials, procedures and locations.
Explore the productsFor readers interested in living longer and better, the first question is what is actually offered. A provider’s repair or anti-aging claim is a claim; trial registration and company quality statements are not product approval.
01 / Our approach
How did we evaluate these products and services?
We compared the providers’ stated cell sources, treatment setting and descriptions of intended use. Category-level FDA warnings are not findings that any named clinic caused a particular injury.
Can Stem Cell Therapy Reverse Aging?: evidence and sources02 / The takeaways
What did the source evidence show?
- Regenexx-SD describes the patient’s own bone marrow; Cell Surgical Network describes cells separated from the patient’s fat.
- BioXcellerator describes donor umbilical-cord cells and treatment in Colombia, not its US corporate office.
- MD Stem Cells explicitly describes investigational, non-FDA-approved study treatments.
What exact material and procedure sit behind the word regenerative?
What safety context matters here?
FDA approval covers a named product for a particular medical use. In December 2024, FDA approved Ryoncil, made from donor bone-marrow cells, for children aged two months and older with a severe transplant complication that has not responded to steroid treatment. The condition is called steroid-refractory acute graft-versus-host disease. That approval does not extend to the anti-aging or wellness services listed here. Primary source
FDA reports serious harms from unapproved regenerative products, including infections, tumor formation and blindness. This category warning does not establish that any named provider caused those harms. The company profiles below describe advertised services; inclusion does not establish approval or benefit for an individual medical use. Primary source
The products and services
What is distinct about each product or service?
The order is not a ranking. Each profile describes the named offering and its practical distinctions.
The matrix summarizes the specific formats and distinctions described in the profiles.
Product 01 / 05
Regenexx-SD bone marrow concentrate procedure
Offering formatPatient’s own bone marrow; orthopedic procedure
Regenexx describes SD as same-day concentration of a patient’s own bone marrow, taken from the back of the pelvis and injected with imaging guidance. The company markets orthopedic uses involving joints, tendons and the spine.
Its course can include separate platelet-rich-plasma visits. Same-day marrow processing does not mean every part of care occurs in one visit. This is different from donor cord cells, laboratory-expanded cells or a general anti-aging infusion.
Product 02 / 05
BioXcellerator stem cell therapy programs
Offering formatDonor-cell programs in Medellín, Colombia
BioXcellerator describes laboratory-expanded cells from donated umbilical-cord tissue and markets orthopedic, neurologic and wellness programs. It reviews medical history for candidacy and says outcomes vary.
The company identifies Medellín as the treatment center; Scottsdale is a corporate office, not a US treatment site. It acknowledges that its therapies are not FDA approved. Its quality-system claims do not establish US authorization.
Product 03 / 05
Ways2Well regenerative care service
Offering formatMenu of distinct regenerative approaches
Ways2Well advertises cell-based approaches, including MuseCells and mesenchymal signaling cells, alongside exosomes—tiny particles released by cells. These are different kinds of material, rather than one uniform stem-cell product. The company uses repair and regeneration language and lists Austin and Houston services with clinician eligibility review.
The menu is not one uniform stem-cell infusion. Exact tissue source and administration route are not specified for every approach in the linked description; those details are not assumed here. A menu listing does not establish FDA approval.
Product 04 / 05
Cell Surgical Network procedures
Offering formatPatient’s own fat-derived cell preparation
The network describes taking fat by liposuction under local anesthesia, separating cells and administering the preparation. It markets uses involving several body systems and routes through network practices.
The network calls its process FDA compliant. That is its statement, rather than proof that every advertised application is FDA approved. A particular clinic’s procedure and eligibility can differ from the network-wide description.
Product 05 / 05
MD Stem Cells — SCOTS 2 and NEST study services
Offering formatInvestigational eye and neurologic study programs
MD Stem Cells describes using a patient’s own bone-marrow-derived cells in its SCOTS 2 eye and NEST neurologic programs, with medical-record review and follow-up. It lists treatment locations in Coral Springs, Florida, and Dubai; Westport is administrative.
Its website explicitly says the treatments are investigational and not FDA approved. Study registration is not NIH endorsement or FDA authorization, and a website listing does not establish current open enrollment for every condition.
Does a stated location refer to treatment, administration or a corporate office?
Reader Questions
A few questions to consider while reading the evidence.
- Which detail changes how you understand the offering?
- What would need an explanation beyond the advertised benefit?
Extra Insights & Sources
For readers who want the evidence and comparison details behind this guide.
Product comparison matrix
How do the products and services compare?
This matrix summarizes the product profiles above. Amounts describe the named label or service, not a personal treatment plan. It is not a scorecard or ranking.
| Question | Regenexx-SD bone marrow concentrate procedure | BioXcellerator stem cell therapy programs | Ways2Well regenerative care service | Cell Surgical Network procedures | MD Stem Cells — SCOTS 2 and NEST study services |
|---|---|---|---|---|---|
| Stated material | Own bone marrow concentrate | Expanded donor cord-tissue cells | Several advertised approaches | Own fat-derived preparation | Own bone-marrow-derived cells |
| Setting / purpose | Orthopedic procedure network | Treatment in Medellín | Austin / Houston listed; clinician eligibility | Network practices; route-specific procedures | Eye / neurologic study programs |
| Key distinction | SD differs from PRP alone | US office is not treatment center | Not one uniform infusion | Compliance statement is provider claim | Explicitly investigational / not FDA approved |
Sources
- Can Stem Cell Therapy Reverse Aging?
- Safety and regulatory source
- Safety and regulatory source
- FDA or official labeling verification
- FDA or official labeling verification
- FDA or official labeling verification
- Exosomes: biological definition
- Regenexx-SD bone marrow concentrate procedure — official listing
- BioXcellerator stem cell therapy programs — official listing
- Ways2Well regenerative care service — official listing
- Cell Surgical Network procedures — official listing
- MD Stem Cells — SCOTS 2 and NEST study services — official listing
Image credits
Disclosures
Company claims are reported with attribution. Product inclusion is not an endorsement, diagnosis or personal treatment recommendation.